Sign In

Bob Shelley

VP Global Market Access & Pricing at Kite Pharma

Bob Shelley is the Vice President of Global Market Access & Pricing at Kite Pharma, a company focused on cell and gene therapies, particularly in oncology. He has over 25 years of experience in the pharmaceutical industry, specializing in areas such as oncology, gene and cell therapy, biosimilars, and ultra-rare diseases.1

In his current role at Kite Pharma, Bob leads efforts to develop strategies that ensure patient access to therapies. His responsibilities include shaping the CAR-T policy and reimbursement landscape, guiding new payment models, and overseeing the execution of pricing and access strategies globally.1 He collaborates with local teams to implement market access strategies effectively.1

Before joining Kite Pharma, Bob was the Vice President of U.S. Market Access at bluebird bio, where he managed the market access strategy for their gene therapy portfolio. His prior experience includes significant roles at Pfizer, where he led biosimilars market access, and Novartis, where he held various positions related to oncology and rare diseases.1

Bob's extensive background in market access and pricing is complemented by his commitment to improving patient outcomes through innovative therapeutic strategies.

Related Questions

What are Bob Shelley's main responsibilities at Kite Pharma?
How has Bob Shelley's experience at bluebird bio influenced his role at Kite Pharma?
What strategies does Bob Shelley implement for patient access at Kite Pharma?
How does Bob Shelley's background in oncology and gene therapy benefit Kite Pharma?
What are some of the key challenges Bob Shelley faces in his role at Kite Pharma?
Bob Shelley
Add to my network

Location

Santa Monica, California, United States